New US FDA Biologics License Pathway Could Be Missing Link To Reduce Animal Testing

A new US FDA regulatory pathway for biologics could simplify efforts to reduce reliance on animal testing (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from R&D

More from Advanced Technologies